Letters In Drug Design & Discovery

Letters In Drug Design & Discovery

药物设计与发现快报

  • 4区 中科院分区
  • Q4 JCR分区

期刊简介

《Letters In Drug Design & Discovery》是由Bentham Science Publishers B.V.出版社于2004年创办的英文国际期刊(ISSN: 1570-1808,E-ISSN: 1875-628X),该期刊长期致力于药物化学领域的创新研究,主要研究方向为医学-医药化学。作为SCIE收录期刊(JCR分区 Q4,中科院 4区),本刊采用OA未开放获取模式(OA占比0%),以发表药物化学领域等方向的原创性研究为核心(研究类文章占比83.06%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在183篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Letters In Drug Design & Discovery审稿周期约为 约3.0个月 。该刊近年未被列入国际预警名单,年发文量约183篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 183 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q4 66 / 72

9%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q4 66 / 72

9.03%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:1.8 SJR:0.222 SNIP:0.364
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q3 107 / 183

41%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q4 125 / 157

20%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q4 154 / 178

13%

期刊发文

  • Design, Synthesis, and Insecticidal Evaluation of New Benzoylureas Containing Carbamate Groups Based on the Bipartite Model of Sulfonylurea Receptor Binding Site

    Author: Zhang, Jingjing; Zhu, Hualing; Xiong, Lixia; Shi, Jun; Huang, Zhiqiang

    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 1, pp. 110-118. DOI: 10.2174/1570180819666220512182621

  • Design, Synthesis, and Anti-Bacterial Evaluation of Tetrahydrobenzothiophene Derivatives as Lipopolysaccharide Biogenesis Inhibitors

    Author: Pei, Shuchen; Yang, Jinhua; Xia, Shihao; Tang, Shuting; Yuan, Kangyao; Chen, Jun

    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 3, pp. 335-342. DOI: 10.2174/1570180819666220317151208

  • Molecular Mechanism of Qingchang Suppository in the Treatment of Ulcerative Colitis Based on Network Pharmacology

    Author: Lin, Zhancheng; Lu, Lu; Zhu, Lingyu

    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 1, pp. 71-76. DOI: 10.2174/1570180819666220509070003

  • Synthesis and Preliminary Biological Evaluation of New Phthalazinone Derivatives with PARP-1 and Cholinesterase Inhibitory Activities

    Author: Lin, Yu; Gao, Chengzhi; Wang, Zhuyong; Zhang, Ruifeng; Chen, Yajun; Min, Zhenli

    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 1, pp. 56-70. DOI: 10.2174/1570180819666220531144809

  • Oxymatrine-induced Apoptosis in Fibroblasts like Synoviocytes via Regulation of miR-146a/TRAF6/JNK1 Axis in Rheumatoid Arthritis

    Author: Li, Jing; Hong, Hua

    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 2, pp. 232-237. DOI: 10.2174/1570180819666220530143250

  • Design and Screening of KLHL22 Inhibitors by Homology Modeling, Molecular Docking, and Molecular Dynamics Simulation

    Author: Gao, Chenglong; Sun, Chuance; Zhang, Lichuan; Zhang, Haoran; Yu, Rilei; Kang, Congmin

    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 3, pp. 291-303. DOI: 10.2174/1570180819666220422101618